Vibrio necrotizing soft-tissue infection of the upper extremity: Factors predictive of amputation and death

Journal of Infection

Volumn 57, Issue 4, 2008, Pages 290-297

  Huang, Kuo Chin ^a,b   Hsieh, Pang Hsin ^a   Huang, Kuo Chung ^c   Tsai, Yao Hung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Chungyu Institute of Technology   (Taiwan)

Author keywords

Necrotizing soft tissue infection; Vibrio infection

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; DOPAMINE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; OXYTETRACYCLINE; TETRACYCLINE;

ADULT; AGED; APACHE; ARM AMPUTATION; ARM DISEASE; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; HUMAN; HYPOALBUMINEMIA; LENGTH OF STAY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; PROGNOSIS; RESUSCITATION; RISK ASSESSMENT; SCORING SYSTEM; SEPTIC SHOCK; SOFT TISSUE INFECTION; SURVIVAL RATE; TREATMENT RESPONSE; VIBRIO; VIBRIO NECROTIZING SOFT TISSUE INFECTION;

ADULT; AGED; AMPUTATION; ANTI-BACTERIAL AGENTS; FEMALE; HAND; HUMANS; MALE; MIDDLE AGED; NECROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SOFT TISSUE INFECTIONS; TREATMENT OUTCOME; UPPER EXTREMITY; VIBRIO; VIBRIO INFECTIONS;

EID: 53249154655     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.07.009     Document Type: Article

References (41)

1. Amaro C., Hor L.I., Marco-Noales E., Bosque T., Fouz B., and Alcaide E. Isolation of Vibrio vulnificus serovar E from aquatic habitats in Taiwan. Appl Environ Microbiol 65 (1999) 1352-1355
2. Morris Jr. J.G. Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell. Clin Infect Dis 37 (2003) 272-280
3. Bisharat N., Agmon V., Finkelstein R., Raz R., Ben-Dror G., Lerner L., et al. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Lancet 354 (1999) 1421-1424
4. Chang-Chien C.H., Ding H.T., Liu C., and Yang C.S. Vibrio infection associated with finning injury of the hand. Injury 38 (2007) 614-618
5. Chiang S.R., and Chuang Y.C. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect 36 (2003) 81-88
6. Huang K.C., and Hsu R.W. Vibrio fluvialis hemorrhagic cellulitis and cerebritis. Clin Infect Dis 40 (2005) e75-e77
7. Tsai Y.H., Hsu R.W., Huang K.C., Chen C.H., Cheng C.C., Peng K.T., et al. Systemic Vibrio infection presenting as necrotizing fasciitis and sepsis. A series of thirteen cases. J Bone Joint Surg Am 86 11 (2004) 2497-2502
8. Hlady W.G., and Klontz K.C. The epidemiology of Vibrio infections in Florida, 1981-1993. J Infect Dis 173 (1996) 1176-1183
9. Kikawa K., Yamasaki K., Sujiura T., Myose H., Chinen M., Tsutsumi K., et al. A successfully treated case of Vibrio vulnificus septicemia with shock. Jpn J Med 29 (1990) 313-319
10. Kim J.J., Yoon K.J., Yoon H.S., Chong Y., Lee SY., Chon CY., et al. Vibrio vulnificus septicemia: report of four cases. Yonsei Med J 27 (1986) 307-313
11. Klontz K.C., Lieb S., Schreiber M., Janowski H.T., Baldy L.M., and Gunn R.A. Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med 109 8 (1988) 318-323
12. Kumamoto K.S., and Vukich D.J. Clinical infection of Vibrio vulnificus: a case report and review of literature. J Emerg Med 16 (1998) 616-666
13. Hsueh P.R., Lin C.Y., Tang H.J., Lee H.C., Liu J.W., Liu Y.C., et al. Vibrio vulnificus in Taiwan. Emerg Infect Dis 10 8 (2004) 1363-1368
14. Liu J.W., Lee I.K., Tang H.J., et al. Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Arch Intern Med 166 (2006) 2117-2123
15. Nakafusa J., Misago N., Miura Y., Kayaba M., Tanaka T., and Narisawa Y. The importance of serum creatine phosphokinase level in the early diagnosis, and as a prognostic factor, of Vibrio vulnificus infection. Br J Dermatol 145 (2001) 280-284
16. Andreasen T.J., Green S.D., and Childers B.J. Massive infectious soft-tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg 107 (2001) 1025-1035
17. Lake C., and Dodson R. Progressive upper limb prosthetics. Phys Med Rehabil Clin N Am 17 1 (2006) 49-72
18. Chuang Y.C., Liu J.W., Ko W.C., Lin K.Y., Wu J.J., and Huang K.Y. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother 41 10 (1997) 2214-2217
19. Chuang Y.C., Ko W.C., Wang S.T., et al. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother 42 6 (1998) 1319-1322
20. Tang H.J., Chang M.C., Ko W.C., Huang K.Y., Lee C.L., and Chuang Y.C. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus. Antimicrob Agents Chemother 46 11 (2002) 3580-3584
21. Hollenberg S.M., Ahrens T.S., Annane D., Astiz M.E., Chalfin D.B., Dasta J.F., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32 (2004) 1928-1948
22. McCluskey A., Thomas A.N., Bowles B.J., and Kishen R. The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 51 8 (1996) 724-727
23. Nicholson J.P., Wolmarans M.R., and Park G.R. The role of albumin in critical illness. Br J Anaesth 85 4 (2000) 599-610
24. Vincent J.L., Dubois M.J., Navickis R.J., and Wilkes M.M. Hypoalbuminemia in acute illness: is there a rationale for intervention?. Ann Surg 237 (2003) 319-334
25. Sung J., Bochicchio G.V., Joshi M., Bochicchio K., Costas A., Tracy K., et al. Admission serum albumin is predictive of outcome in critically ill trauma patients. Am Surgeon 70 (2004) 1099-1102
26. Edge K., Chinoy H., and Cooper R.G. Serum alanine aminotransferase elevations correlate with serum creatine phosphokinase levels in myositis. Rheumatology 45 (2006) 487-488
27. Janssen G.M., Kuipers H., Willems G.M., Does R.J., Jassen M.P., and Geurten P. Plasma activities of muscle enzymes: quantification of skeletal muscle damage and relationship with metabolic variables. Int J Sports Med 10 (1989) S160-S168
28. Fernandez A., and Justinani F.R. Massive rhabdomyolysis: a rare presentation of primary Vibrio vulnificus septicemia. Am J Med 89 (1990) 535-536
29. Simonart T., Nakafusa J., and Narisawa Y. The importance of serum creatine phosphokinase level in the early diagnosis and microbiological evaluation of necrotizing fasciitis. J Eur Acad Dermatol 18 (2004) 687-690
30. Brandt M.M., Corpron C.A., and Wahl W.L. Necrotizing soft tissue infections: a surgical disease. Am Surgeon 66 (2000) 967-970
31. Fujisawa N., Yamada H., Kohda H., Tadano J., and Hayashi S. Necrotizing fasciitis caused by Vibrio vulnificus differs from that caused by streptococcal infection. J Infect 36 (1998) 313-316
32. Wong C.H., Chang H.C., Pasupathy S., Khin L.W., Tan J.L., and Low C.O. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85 8 (2003) 1454-1460
33. Chuang Y.C., Sheu H.M., Ko W.C., Chang T.M., Chang M.C., and Huang K.Y. Mouse skin damage caused by a recombinant extracellular metalloprotease from Vibrio vulnificus and by Vibrio vulnificus infection. J Formos Med Assoc 96 9 (1997) 667-684
34. Miyoshi S. Vibrio vulnificus infection and metalloprotease. J Dermatol 33 9 (2006) 589-595
35. Miyoshi S., Nakazawa H., Kawata K., Tomochika K., Tobe K., and Shinoda S. Characterization of the hemorrhagic reaction by Vibrio vulnificus metalloprotease, a member of the thermolysin family. Infect Immun 66 (1998) 4851-4855
36. Shin S.H., Shin D.H., Ryu P.Y., Chung S.S., and Rhee J.H. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera. FEMS Immunol Med Microbiol 33 (2002) 133-138
37. Hor L.I., Chang T.T., and Wang S.T. Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: Association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis 179 (1999) 275-278
38. O'Malley S.M., Mouton S.L., Occhino D.A., Deanda M.T., Rashidi J.R., Fuson K.L., et al. Comparison of the heme iron utilization systems of pathogenic vibrios. J Bacteriol 181 11 (1999) 3594-3598
39. Kashimoto T., Ueno S., Hanajima M., Hayashi H., Akeda Y., Miyoshi S., et al. Vibrio vulnificus induces macrophage apoptosis in vitro and in vivo. Infect Immun 71 1 (2003) 533-535
40. Wong C.H., Khin L.W., Heng K.S., Tan K.C., and Low C.O. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 32 7 (2004) 1535-1541
41. Wong C.H., and Wang Y.S. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis 18 (2005) 101-106